Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Ethical Issues in Synthetic Biology: New Report Calls for a Broad Ethics of Emerging Technologies

Abstract:
The emerging field of synthetic biology will allow researchers to create biological systems that do not occur naturally as well as to re-engineer existing biological systems to perform novel and beneficial tasks. Synthetic biology promises significant advances in areas such as biofuels, specialty chemicals, agriculture, and medicine but also poses potential risks. As the science and its applications develop, a comprehensive approach to addressing ethical and social issues of emerging technologies as a whole is called for if scarce intellectual resources are to be used optimally, according to a new report authored by Erik Parens, Josephine Johnston, and Jacob Moses of The Hastings Center.

Ethical Issues in Synthetic Biology: New Report Calls for a Broad Ethics of Emerging Technologies

Washington, DC | Posted on June 3rd, 2009

In Ethical Issues in Synthetic Biology: An Overview of the Debates, the authors examine how the ethical issues raised by a variety of emerging technologies are often similar and familiar. They find that these similarities are abundant enough to justify an effort to develop an ethical framework that cuts across emerging and converging technologies. Indeed, rather than stovepiping ethical questions into the hyphenated areas of bio-ethics, nano-ethics, neuro-ethics and so on, it is time to begin speaking about the ethics of emerging technologies as a whole.

On June 24, Erik Parens will discuss the report's findings, exploring the differences between physical and non-physical harms and pro-actionary and pre-cautionary frameworks, in an effort to better define the ethical issues around synthetic biology. Gregory Kaebnick, also of The Hastings Center, will describe the Center's new, multi-year project that will examine the ethical issues raised in the report in greater depth.

You must register to attend this event: RSVP
www.synbioproject.org/about/contact/rsvp/
No registration necessary to view the webcast

Ethical Issues in Synthetic Biology

When
Wednesday, June 24, 2009, 12:30-1:30 PM (light lunch available at 12 noon)

Who
Erik Parens, Senior Research Scholar, The Hastings Center
Gregory Kaebnick, Research Scholar, The Hastings Center
David Rejeski, Moderator, Director, Synthetic Biology Project

Where
5th Floor Conference Room, Woodrow Wilson International Center for Scholars

####

About Synthetic Biology Project
The Synthetic Biology Project was established as an initiative of the Foresight & Governance Program of the Woodrow Wilson International Center for Scholars.

The Project aims to foster informed public and policy discourse concerning the advancement of synthetic biology an emerging interdisciplinary field that uses advanced science and engineering to make or re-design living organisms, such as bacteria, so they can carry out specific functions. Synthetic biology involves making new genetic code, also known as DNA, which does not already exist in nature.

The Synthetic Biology Project provides independent, rigorous analysis that can inform critical decisions affecting the research, commercialization and use of synthetic biology. Its objective is to help ensure that, as synthetic biology moves forward, possible risks are minimized and benefits maximized.

In collaboration with researchers, governments, industries, non-governmental organizations, policymakers and others, the Project will work to identify gaps in our knowledge of the potential risks of synthetic biology, explore public perceptions towards the field, and examine governance options that will both ensure public safety and facilitate innovation.

All research results, reports, and the outcomes of our meetings and programs will be made broadly available through publications and over the World Wide Web. We include a wide variety of stakeholders, both domestic and international, in our work.

For more information, please click here

Contacts:
Natalie Chin
(202) 691-4318

Copyright © Woodrow Wilson International Center for Scholars

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Synthetic Biology

Nanoscience and the future of healthcare kick off first day of ACS national meeting in Boston: Presidential events highlight safety, diversity and groundbreaking research August 2nd, 2018

Synthetic protein packages its own genetic material and evolves computationally designed protein assemblies are advancing research in synthetic life and in targeted drug delivery December 15th, 2017

Report highlights opportunities and risks associated with synthetic biology and bioengineering November 22nd, 2017

Living computers: RNA circuits transform cells into nanodevices July 27th, 2017

Announcements

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

NUS researchers invent new test kit for quick, accurate and low-cost screening of diseases: Test results are denoted by a color change and could be further analyzed by a smartphone app, making it attractive as a point-of-care diagnostic device September 19th, 2018

Events/Classes

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences August 31st, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project